1. Home
  2. PHR vs NEO Comparison

PHR vs NEO Comparison

Compare PHR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phreesia Inc.

PHR

Phreesia Inc.

HOLD

Current Price

$12.26

Market Cap

713.2M

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.51

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHR
NEO
Founded
2005
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
713.2M
1.6B
IPO Year
2019
2008

Fundamental Metrics

Financial Performance
Metric
PHR
NEO
Price
$12.26
$9.51
Analyst Decision
Strong Buy
Buy
Analyst Count
17
7
Target Price
$30.65
$11.14
AVG Volume (30 Days)
2.0M
1.8M
Earning Date
03-09-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
59.36
N/A
EPS
0.02
N/A
Revenue
$419,813,000.00
N/A
Revenue This Year
$15.56
$10.53
Revenue Next Year
$15.08
$9.25
P/E Ratio
$614.75
N/A
Revenue Growth
17.83
N/A
52 Week Low
$11.31
$4.72
52 Week High
$32.76
$13.74

Technical Indicators

Market Signals
Indicator
PHR
NEO
Relative Strength Index (RSI) 38.70 29.87
Support Level $11.58 $9.13
Resistance Level $12.79 $11.02
Average True Range (ATR) 0.64 0.65
MACD 0.18 -0.11
Stochastic Oscillator 64.19 9.18

Price Performance

Historical Comparison
PHR
NEO

About PHR Phreesia Inc.

Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: